Effects of Maternal Exposure to Lamotrigine during Pregnancy on Gonadal Toxicity in Fetus Rats
DOI:
https://doi.org/10.31661/gmj.v9i.1557Keywords:
Lamotrigine; Pregnancy; Embryo; Testicular; OvaryAbstract
Background: Lamotrigine is one of the newest antiepileptic drugs that is used as one of the most common treatments in pregnancy. Since the investigation of the teratogenic effects of lamotrigine is very limited and there is no report of its teratogenic effects on fetal gonads, we aimed to investigate the teratogenic effects of lamotrigine on embryonic gonads. Materials and Methods: This study was performed on nine female Wistar female rats (8 weeks, weighing 180-200 mg). At first, the animals were inspected regularly by the preparation of vaginal smear and in the estrus phase in separate cages of mating, and after observing the vaginal plaque, were randomly divided into three groups (n=3). Control group did not receive any treatment. In the lamotrigine group (20mg/kg), and the vehicle group (same volume of normal saline) were injected intraperitoneally from days 8 to 13 of pregnancy. On day 20, animals were anesthetized by sodium pentobarbital (40 mg/kg), and embryos were extracted through laparotomy. First, fetuses were weighed, and their height (crown-rump length) was measured. Then the gonads of the fetuses were removed and, stained with H & E, and examined by optical microscope. Results: Our results showed that in the lamotrigine group, the number of seminiferous tubules and Sertoli cells in the male embryos and the number of oocytes in the female embryos decreased significantly compared to the control and vehicle groups (P≤0.05). Conclusion: The results of this study showed that treatment with 20 mg/kg lamotrigine in mothers during pregnancy could cause damage to fetal gonads. [GMJ.2020;9:e1557]
References
Saboory E, Roshan-Milani S, Ahmadzadeh R, Pilehvarian A A. Exposure to Predator Stress in Gestational Period Potentiates Pilocarpine induced Epileptic Behaviors in offspring of rat. Physiol Pharmacol. 2011; 15 (2) :190-200 Poursadeghfard M, Hashemzehi Z, Ashjazadeh N. Status Epilepticus in Adults: A 6-Year Retrospective Study. Galen Medical Journal. 2014;3(3):153-59. Amirpour-najafabadi B, Gholami M, Zarie P, Hossieni S, Sadegh M. Effect of sodium valproate on adjusting increased hippocampal levels of NF-KB, S100B and GFAP following alloxan induced diabetes. SJKU. 2018; 23 (5) :78-87 Afshar M. INFANT WITH HYDANTOIN SYNDROME DUE TO PRENATAL PHENOBARBITAL EXPOSURE. RJMS. 2002; 8 (27) :523-8. [in Persian] Antonucci R, Cuzzolin L, Manconi A, Cherchi C, Oggiano AM, Locci C. Maternal Carbamazepine Therapy and Unusual Adverse Effects in a Breastfed Infant. Breastfeeding Medicine. 2018 Mar 1;13(2):155-7. https://doi.org/10.1089/bfm.2017.0235PMid:29431474 Dolk H, Jentink J, Loane M, Morris J, de Jong-van den Berg LT. Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations?. Neurology. 2008;71(10):714-22. https://doi.org/10.1212/01.wnl.0000316194.98475.d8PMid:18650491 Rahmani F. The teratogenic effect of lamotrigine on vertebral column, sternum and ribs of mice fetus. J Shahrekord Univ Med Sci. 2006; 7 (4) :1-7. [in Persian] Prakash PL, Nasar MA, Rai R, Madhyastha S, Singh G. Lamotrigine in pregnancy: safety profile and the risk of malformations. Singapore Med J. 2007;48(10):880-3. Campbell E, Kennedy F, Russell A, Smithson WH, Parsons L, Morrison PJ, Liggan B, Irwin B, Delanty N, Hunt SJ, Craig J. Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers. J Neurol Neurosurg Psychiatry. 2014 Sep 1;85(9):1029-34. https://doi.org/10.1136/jnnp-2013-306318PMid:24444855 Prakash C, Hatters-Friedman S, Moller-Olsen C, North A. Maternal and fetal outcomes after lamotrigine use in pregnancy: a retrospective analysis from an urban maternal mental health center in New Zealand. Psychopharmacology bulletin. 2016;46(2):63. Tennis P, Eldridge RR. Preliminary results on pregnancy outcomes in women using lamotrigine. Epilepsia. 2002;43(10):1161-7. https://doi.org/10.1046/j.1528-1157.2002.45901.xPMid:12366730 Sathiya S, Ganesh M, Kalaivani P, Ranju V, Janani S, Pramila B, Saravana Babu C. Prenatal exposure to lamotrigine: effects on postnatal development and behaviour in rat offspring. ISRN neuroscience. 2014;2014. https://doi.org/10.1155/2014/163459PMid:24967313 PMCid:PMC4045557 Røste LS, Taubøll E, Isojärvi JI, Berner A, Berg KA, Pakarinen AJ, T HUHTANIEMI IL, Knip M, Gjerstad L. Gonadal morphology and sex hormones in male and female Wistar rats after long-term lamotrigine treatment. Seizure. 2003 Dec 1;12(8):621-7. https://doi.org/10.1016/S1059-1311(03)00056-6 Khezri Motlagh R, Mokhtari M, Shariati M, Changizi- Ashtiyani S, Moghadamnia D. The Effect of Antiepileptic Drug of Lamotrigine, on the Function of Reproductive Hormones in Male Rats. AUMJ. 2016; 5 (3) :179-186. https://doi.org/10.18869/acadpub.aums.5.3.179 Daoud AS, Bataineh H, Otoom S, Abdul-Zahra E. The effect of Vigabatrin, Lamotrigine and Gabapentin on the fertility, weights, sex hormones and biochemical profiles of male rats. Neuroendocrinology Letters. 2004;25(3):178-83. Ohman I, Vitols S, Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia. 2000;41(6):709-13. https://doi.org/10.1111/j.1528-1157.2000.tb00232.xPMid:10840403
